Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2022-04-22 Report Publication Anno…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
关于举行2021年度报告网上业绩说明会的公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (879 characters) about the company Yingkang Life Technology Co., Ltd. holding an online performance explanation meeting for the 2021 Annual Report. It states the date and time of the meeting, the disclosure of the 2021 Annual Report and its summary on a website, and invites investors to participate and submit questions. There is no actual financial data or detailed report content included, only an announcement of the event and report availability. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA) rather than the Annual Report (10-K) itself.
2022-04-22 Chinese
关于监事辞职及补选监事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company supervisor (监事) and the election of a new supervisor. It includes details about the resignation, the replacement process, and the biography of the newly appointed supervisor. There is no financial data, no mention of financial results, no regulatory certifications, or report publications. The content clearly relates to changes in company management personnel, specifically the supervisory board. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused on personnel changes, not a report or announcement of a report publication.
2022-04-22 Chinese
关于使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by 盈康生命科技股份有限公司 regarding the progress of using idle self-owned funds for cash management. It details the approval process, amounts invested, types of financial products purchased, redemption details, risk control measures, and impact on company operations. The document is an update on financing activities related to cash management and investment of idle funds, not a full financial report or earnings release. It does not contain comprehensive financial statements or quarterly/yearly results. The document length is under 5,000 characters and is a specific announcement about capital usage and investment activities. Therefore, it fits best under Capital/Financing Update (CAP).
2022-04-22 Chinese
关于解除托管杭州怡康中医肿瘤医院有限公司事项的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Yingkang Life Technology Co., Ltd. regarding the termination of a management entrustment agreement related to Hangzhou Yikang Traditional Chinese Medicine Oncology Hospital. It details the background, the agreement to terminate the entrustment, the reasons for termination, and the impact on the company. The document is a formal disclosure of a corporate event affecting management and operational arrangements but does not contain financial statements, audit information, or detailed financial results. It is not a report, earnings release, or regulatory certification. The content fits best as a regulatory announcement about a corporate operational change, which aligns with the category of Regulatory Filings (RNS). The document length is short (1748 characters), and it is a standalone announcement rather than a report or presentation. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-04-01 Chinese
独立董事关于第五届董事会第二十二次（临时）会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding a specific board meeting (the 22nd extraordinary meeting of the 5th board) and related matters, specifically about a related-party transaction involving a subsidiary. It references compliance with listing rules and governance codes but does not contain financial statements or detailed financial results. The document is a formal opinion related to board/management matters rather than a full report or announcement of voting results. It is not a general regulatory filing or a report publication announcement. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on governance and board opinions, confirming this classification.
2022-03-29 Chinese
关于子公司向关联方销售医疗设备暨关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a related party transaction where a subsidiary sells medical equipment to an affiliated company. It includes details of the transaction, approval by the board and supervisory committee, independent directors' opinions, and compliance with regulatory rules. There are no financial statements or comprehensive financial data presented, nor is this a report or transcript. The document is a formal disclosure of a related party transaction, which is a regulatory announcement. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a voting result or capital change. Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2022-03-29 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.